Abstract
502P Nivolumab, alone or with ipilimumab, for mismatch repair deficient metastatic colorectal cancer: A United Kingdom multicentre analysis of patient outcomes
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have